about
Polypoidal Choroidal Vasculopathy in AsiansPolypoidal choroidal vasculopathy: an update on therapeutic approachesProspective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month resultsPolypoidal choroidal vasculopathy in Chinese patients.Argon laser photocoagulation for the treatment of polypoidal choroidal vasculopathy.Early signs of exudative age-related macular degeneration in AsiansC2 rs547154 polymorphism and polypoidal choroidal vasculopathy susceptibility: a meta-analysis.Ethnic differences in the association of SERPING1 with age-related macular degeneration and polypoidal choroidal vasculopathy.Analysis of candidate genes for age-related macular degeneration subtypes in the Japanese populationEVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathyPolypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation.Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiographyAngiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epitheliumIntravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps.Evidence of a novel gene HERPUD1 in polypoidal choroidal vasculopathy.The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathyTwo-year results of intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcomePolypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab responseIdiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization.Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study.Protocol for a randomised, double-masked, sham-controlled phase 4 study on the efficacy, safety and tolerability of intravitreal aflibercept monotherapy compared with aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopaOverexpression of HTRA1 leads to down-regulation of fibronectin and functional changes in RF/6A cells and HUVECs.Efficacy of intravitreal aflibercept in Japanese patients with exudative age-related macular degeneration.Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration.Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography.Idiopathic polypoidal choroidal vasculopathy in a Caucasian man: problems of diagnosis and treatment.Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population.Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.Comparison of photodynamic therapy to transpupillary thermotherapy for polypoidal choroidal vasculopathy.Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy.Sensitivity, Specificity, and Limitations of Optical Coherence Tomography Angiography in Diagnosis of Polypoidal Choroidal Vasculopathy.Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of 'expanded spectra' - a review.Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.Polypoidal choroidal vasculopathy in patients diagnosed with neovascular age-related macular degeneration in Denmark.Clinical characteristics of polypoidal choroidal vasculopathy in Chinese patients.Retreatment of polypoidal choroidal vasculopathy after photodynamic therapy combined with intravitreal ranibizumab.Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom.
P2860
Q26799548-D9887C90-8622-46F9-BA9C-FD921670ECC2Q27006758-AF15DC58-A206-4816-A307-03882AFBA6A3Q27311334-E1DD3D3B-BBDA-4DC5-8753-C33A28C39BBFQ31098011-3E2C4C29-733C-41F5-8043-50DC289DBCA4Q33295175-6F4D3BF2-CD0F-4965-ADA2-A7B5BFDF177FQ34293886-07C7570D-786F-4938-9367-7B012023CEECQ35138698-B3AF8269-6796-4E33-996C-D01DD16ED63CQ35210581-928FC2AF-2754-4210-8F95-96925A2263CDQ35531888-2A2B071C-A4F5-4D2D-8F15-C80F7D95CF6BQ35550819-10F13B5B-0EA7-4029-86B6-4EDE484B5D56Q35589482-C0E8771E-75A6-4D90-BE5F-FF624FC9D1FAQ35954073-D508E09B-92AB-4547-9E55-99A21100458EQ36089419-55D67073-69F4-43A4-B758-CB876CE151F9Q36343000-82BE449F-BB52-4230-AEC4-FD92874B5A8AQ36464296-EE06EDA8-1646-47F4-A1A9-1413DAA111BAQ37070218-9B8C9F21-1C65-488B-AA41-23CF9AEA25FDQ37087140-CA71534F-EB33-4FAD-AA70-8C63FA6611CFQ37536361-ABE4505C-8071-4D54-9AB3-076E49115736Q37552779-B96DACDD-A660-4A49-9595-3C28EF37DD7CQ37641461-BC8A270C-C626-4828-9B9A-247D48477A30Q37662693-AE6B1926-87FF-4004-B9B2-7E1055E383F9Q38371503-498AA556-0014-406C-A0B0-46D1640D0184Q39261579-90AD1708-5C1C-4F2D-91AC-9E684C53F57FQ40569047-47F7F4C2-F1B9-4371-ADF5-53AEA9B59A99Q41995683-DCA9C1E6-B8A6-4F83-9F50-81EAF93734EBQ42372998-A3197714-2CCC-4E38-BADB-51E688702CACQ42410067-7690B8D3-AD59-4EF2-AB9A-6D5D580059EFQ44670770-71752ABD-1E89-4CA1-B2DA-62CF12D50F5FQ44887000-613323EF-E0E6-4127-B99B-B93E78A840D6Q46887088-2927C75E-C606-4E0A-9AF7-57B19C65E950Q46976985-5233DC33-DB1D-4773-B1CA-9C02689640FBQ47117628-F47125E2-2CBD-4DC7-8665-7C594642394AQ47643324-A2614E10-34FE-48AB-9626-ED98B19CD6BCQ47852586-2D4E7614-26FB-4E67-8115-A035157A73E5Q48232207-C4EC64CF-FCDF-4268-BFE7-189B1EFDA1EDQ50482167-7E2BEB90-3D81-4222-A56E-25A996278DDDQ50503612-DF1869B0-55F1-4A2D-9F0A-83A6B4A0C130Q50531428-3F2CF8F8-9419-4333-AA39-5A5E01F9EE5CQ51469037-4EDD780F-637B-44DD-B1FC-B030B03BF7A0Q52944872-492F141C-5EE5-4833-9047-C317F2DC1A0E
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Polypoidal choroidal vasculopathy in Caucasians.
@ast
Polypoidal choroidal vasculopathy in Caucasians.
@en
type
label
Polypoidal choroidal vasculopathy in Caucasians.
@ast
Polypoidal choroidal vasculopathy in Caucasians.
@en
prefLabel
Polypoidal choroidal vasculopathy in Caucasians.
@ast
Polypoidal choroidal vasculopathy in Caucasians.
@en
P2093
P356
P1476
Polypoidal choroidal vasculopathy in Caucasians.
@en
P2093
P2888
P304
P356
10.1007/S004170000180
P577
2000-09-01T00:00:00Z
P6179
1041667405